SUBSCRIBE: Print / eNewsletter
Cancer Risk Elevated Among Holocaust Survivors
Holocaust survivors have a small but consistent increase in the risk of developing cancer, in particular colorectal and lung cancers.
PARP Inhibitors Effective but Costly for Recurrent Ovarian Cancer
Niraparib is the most effective but most costly of the currently FDA-approved PARP inhibitors for the treatment of recurrent ovarian cancer.
Optical Technology Detects Cancer With High Accuracy During Surgery
An intraoperative, multimodal optical cancer detection system can detect brain cancer with high degrees of accuracy, sensitivity, and specificity in real time during surgery, according to a new study.
Peptide Vaccine Shows Clinical Benefit in Glioblastoma
A personalized peptide vaccination shows clinical benefit for human leukocyte antigen-A24-positive glioblastoma multiforme patients refractory to temozolomide-based therapy.
Medicaid Restrictions Negatively Impact Poor Breast Cancer Patients
Limiting Medicaid enrollment has the potential for negative health impacts, in particular among low-income women with a diagnosis of breast cancer, according to a new study.
Immunotherapy Safely Treats Advanced Squamous Cell Carcinoma
An anti–PD-1 monoclonal antibody is safe and effective for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.
Docetaxel-Based Triplet New Standard in Gastric Cancer
Perioperative chemotherapy with a docetaxel-based triplet should be considered the new standard of care for resectable gastric or GEJ adenocarcinoma.
Alectinib Touted as New Standard of Care for ALK-Positive Lung Cancer
The second-generation ALK-inhibitor alectinib should be the new standard of care for first-line treatment of ALK-positive non–small-cell lung cancer, according to a new study.
Immunotherapy Yields ‘Dramatic’ Response Rates in Relapsed Mesothelioma
Immunotherapy may represent an effective new treatment approach for relapsed mesothelioma patients, according to a new study.
Breast Cancer Survivors Can Safely Become Pregnant
Breast cancer survivors, including those with estrogen receptor–positive tumors, can safely become pregnant, according to a new study.